Literature DB >> 1434854

Immunofluorescent staining for mast cells in idiopathic pulmonary fibrosis: quantification and evidence for extracellular release of mast cell tryptase.

L W Hunt1, T V Colby, D A Weiler, S Sur, J H Butterfield.   

Abstract

In many diseases, retrospective analysis for determining the presence of mast cells has been difficult because of their loss of metachromatic staining properties once tissue has undergone formalin fixation. We quantified mast cells in peribronchiolar tissue of idiopathic pulmonary fibrosis (IPF) and in normal human lung by using rabbit antiserum to human mast cell tryptase. In lung biopsy specimens from 15 patients with IPF, the mean number of mast cells per high-power field in connective tissue directly adjacent to the lumen of small airways (0.5 to 2 mm in diameter) and other fibrotic foci was 29.9 +/- 10.8 in comparison with 13.7 +/- 3.5 in 16 normal controls (P < 0.001). In addition, mast cells in cases of IPF had an altered appearance--irregularity of the plasma membrane and release of extracellular tryptase. We conclude that the number of mast cells is increased in IPF and that the altered appearance of the mast cells suggests that they are activated and undergoing degranulation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1434854     DOI: 10.1016/s0025-6196(12)60924-0

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  24 in total

Review 1.  Mucosal mast cells are pivotal elements in inflammatory bowel disease that connect the dots: stress, intestinal hyperpermeability and inflammation.

Authors:  Ashkan Farhadi; Jeremy-Z Fields; Ali Keshavarzian
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

2.  Distribution of mast cells in human ileocecal region.

Authors:  S Bacci; S Faussone-Pellegrini; B Mayer; P Romagnoli
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

3.  A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis.

Authors:  Yasmina Bauer; John Tedrow; Simon de Bernard; Magdalena Birker-Robaczewska; Kevin F Gibson; Brenda Juan Guardela; Patrick Hess; Axel Klenk; Kathleen O Lindell; Sylvie Poirey; Bérengère Renault; Markus Rey; Edgar Weber; Oliver Nayler; Naftali Kaminski
Journal:  Am J Respir Cell Mol Biol       Date:  2015-02       Impact factor: 6.914

4.  Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts.

Authors:  J A Cairns; A F Walls
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

Review 5.  Neuroinflammatory Mechanisms of Connective Tissue Fibrosis: Targeting Neurogenic and Mast Cell Contributions.

Authors:  Michael J Monument; David A Hart; Paul T Salo; A Dean Befus; Kevin A Hildebrand
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

6.  Lung mast cell density defines a subpopulation of patients with idiopathic pulmonary fibrosis.

Authors:  Seung-Ick Cha; Christine S Chang; Eun Kyung Kim; Jae W Lee; Michael A Matthay; Jeffrey A Golden; Brett M Elicker; Kirk Jones; Harold R Collard; Paul J Wolters
Journal:  Histopathology       Date:  2012-03-06       Impact factor: 5.087

7.  Fibroproliferation and mast cells in the acute respiratory distress syndrome.

Authors:  J M Liebler; Z Qu; B Buckner; M R Powers; J T Rosenbaum
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 8.  Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis.

Authors:  Eric S White; Michael H Lazar; Victor J Thannickal
Journal:  J Pathol       Date:  2003-11       Impact factor: 7.996

9.  Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma.

Authors:  Z Qu; J M Liebler; M R Powers; T Galey; P Ahmadi; X N Huang; J C Ansel; J H Butterfield; S R Planck; J T Rosenbaum
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

Review 10.  Key role of mast cells and their major secretory products in inflammatory bowel disease.

Authors:  Shao-Heng He
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.